Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program

Background: Medications such as buprenorphine are considered the gold standard for the treatment of opioid use disorders. This study aimed to determine whether less restrictive buprenorphine prescribing practices during the COVID-19 pandemic impacted retention in and adherence to buprenorphine among...

Descrición completa

Detalles Bibliográficos

Principais autores:	Kathleen M. Ward, Ayden Scheim, Jonathan Wang, Benjamin Cocchiaro, Katie Singley, Alexis M. Roth
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2022-06-01
Series:	Drug and Alcohol Dependence Reports
Assuntos:	Opioid use disorder Retention Adherence People who use drugs Buprenorphine COVID-19
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2772724622000336
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!